Atlas Trials

Study of QRH-882260 Heptapeptide Application in the Colon

Clinical trial NCT03148119 · TERMINATED

Trial details

NCT number
NCT03148119
Sponsor
Danielle Kim Turgeon
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Colon Cancer Prevention
Start date
2017-03-31
Primary completion
2017-07-11
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.